By looking at the individual S100B value distribution during 1 year and single-case analysis of outliers as well as comparison of the distribution by benchmark with other hospitals and previous years, changes in complication rates, unusually high mortality rates (not directly associated with the stroke or MT), and trends toward improvement and deterioration of procedure quality can be detected early. This evidence concerns the gene S100B and Stroke.